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ABSTRACT 
Synthetic biological macromolecule of magnetoferritin containing an iron oxide core inside a 
protein shell (apoferritin) is prepared with different content of iron. Its structure in aqueous 
solution is analyzed by small-angle synchrotron X-ray (SAXS) and neutron (SANS) scattering. 
The loading factor (LF) defined as the average number of iron atoms per protein is varied up to 
LF=800. With an increase of the LF, the scattering curves exhibit a relative increase in the total 
scattered intensity, a partial smearing and a shift of the match point in the SANS contrast 
variation data. The analysis shows an increase in the polydispersity of the proteins and a 
corresponding effective increase in the relative content of magnetic material against the protein 
moiety of the shell with the LF growth. At LFs above ~150, the apoferritin shell undergoes 
structural changes, which is strongly indicative of the fact that the shell stability is affected by 
iron oxide presence. 
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1. INTRODUCTION 
Apoferritin being a part of the natural biological macromolecule of ferritin [1] represents 
a very useful confinement of magnetic nanoparticles inside for biomedical applications [2,3]. 
This almost spherical protein shell with an external diameter of 12 nm and thickness of about 
2.5 nm makes it possible to disperse nanoparticles (by placing them in its cavity) in biological 
media and additionally minimize their possible toxic effect. It also prevents the bulk aggregation 
of nanoparticles and restricts their maximal size. In case of magnetic nanoparticles (Fe3O4, γ-
Fe2O3) placed inside an apoferritin shell the corresponding protein is known as magnetoferritin 
[4]. It is of current interest for various biomedical applications, which make use of the magnetic 
properties of nanoparticles, such as targeted drug transport, magnetic resonance imaging, etc.  
[5,6]. In addition to biocompatibility another advantage of magnetoferritin is the relatively short 
time of synthesis, in which the magnetite (Fe3O4) is formed inside the protein cavity. Through 
the regulation of the iron-to-apoferritin ratio it is possible to prepare homogeneously dispersed 
magnetoferritin molecules with different iron oxide loading. Number of iron atoms per one 
molecule of protein shell is referred to as a loading factor (LF) [7].  
In the previous studies the structure characterization of the magnetic core at various LFs 
was performed mostly by transmission electron microscopy (TEM). In particular, an increase in 
the magnetic nanoparticle size with the LF growth and non-spherical core shapes for low LFs 
were reported [7,8]. It was also found that for quite high LFs (>1000) particle aggregates are 
formed [7,9]. By separating and extracting the non-aggregated particles having magnetic core, 
the uniform magnetoferritine molecules can be crystallized to a 3D ordered magnetic array [10]. 
A number of experiments have been done to characterize the mineral composition of a synthetic 
magnetoferritin core. Thus, Mössbauer spectroscopy showed [11] that it is rather different from 
that of native ferritin. Faraday rotation measurements showed [12] that the composition of the 
core changes with increasing LF starting from maghemite with a relatively small fraction (about 
10%) of magnetite at LF <1250 and varying towards 100 % of magnetite at LFs > 3250. 
One can see that the previous studies of magnetoferrtin were mainly focused on the 
samples with LFs approaching the upper limit of the possible iron oxide content within the 
protein shell. However, recent investigations showed [13,14] that some structural changes of the 
protein shell, and also the organization of magnetoferritin in solutions are observed already at 
significantly lower LFs. The present paper aims at studying the influence of the magnetic content 
of magnetoferritin on the structure of the protein shell at low and moderate iron oxide loadings 
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(LF < 800) by small-angle X-rays (SAXS) and neutron (SANS) scattering in order to provide 
additional and detailed characterization of this novel material and to follow the possible 
modifications of the protein cage in a wide interval of the iron oxide loading. Both kinds of the 
small-angle scattering technique cover the length scale of 1-100 nm, but have different 
sensitivity to the same elements. Especially, it concerns hydrogen whose replacement with 
deuterium provides wide possibilities of the so-called contrast variation in SANS. SAXS, in turn, 
is highly sensitive to the heavier atoms, such as iron. Here, the general size characteristics of 
magnetoferritin and their aggregates in aqueous solutions are first obtained by analyzing SAXS 
and SANS data complemented by the dynamic light scattering (DLS) measurements. Then, the 
SANS contrast variation is additionally applied based on the mixtures of heavy and light water to 
conclude about the composition of magnetoferritin. 
 
2. MATERIALS AND METHODS 
Natural apoferritin (horse spleen) was purchased from Sigma-Aldrich. Magnetoferritin 
with various LFs up to 800 was synthesized in anaerobic conditions at 65°C and alkaline pH as 
described in details elsewhere [15,16]. First, apoferritin was added into the AMPSO (3-[(1,1-
Dimethyl-2-hydroxyethyl)amino]-2-hydroxy-propanesulfonic acid) buffer (0.05 M AMPSO 
buffered with 2 M NaOH to pH 8.6) to achieve protein concentration 6 mg∙mL-1. The buffer was 
deaerated for 55 minutes with nitrogen and for further 5 minutes after the addition of apoferritin. 
Then the solution in the reaction bottle was hermetically closed and placed in preheated water 
bath with temperature 65°C on a magnetic stirrer. Next, deaerated solutions of reactants, 
trimethylamine N-oxide and ferrous ammonium sulfate hexahydrate, were added dropwise into 
the reaction bottle. After the synthesis all samples were filtered through 200 nm filter to remove 
possible aggregates. The average loading factor of each sample was determined using UV-VIS 
spectrophotometer SPECORD 40 (Analytik Jena, Germany). Protein concentration was 
determined using the standard Bradford method at wavelength (λ) 595 nm and the amount of 
iron was measured after HCl/H2O2 oxidation and KSCN addition by light absorption of 
thiocyanate complex at λ = 400 nm.  
Dynamic light scattering measurements were made on a Zetasizer Nano ZS 3600 
(Malvern Instruments) at 25°C. The samples were diluted with 0.15 M NaCl to achieve the 
protein concentration of ~ 0.2 mg∙mL-1 and filtered through a 0.2 µm syringe filter before 
measurement. 
For SANS contrast variation experiments magnetoferritin samples were freeze-dried for 
24 hours after the synthesis to obtain a powder. 10 mg∙mL-1 solutions regarding the protein 
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concentration were prepared by dissolving powders in H2O/D2O mixtures with varying the D2O 
volume fraction. The mixtures of AMPSO buffer (0.05 M AMPSO buffered with 2 M NaOH to 
get pH 8.6) with the same ratios of H2O/D2O as in the samples, were used as background 
solutions. 
SAXS experiments were performed at the P12 BioSAXS beamline of the European 
Molecular Biology Laboratory (EMBL) at the storage ring PETRA III of the Deutsche 
Elektronen Synchrotron (DESY, Hamburg, Germany) at 20°C using a Pilatus 2M detector 
(14751679 pixels) (Dectris, Switzerland) and synchrotron radiation with a wavelength 
λ = 0.1 nm. The sample-detector distance was 3 m, allowing for measurements in a q-range of 
0.11-4.4 nm
-1
. The q-range was calibrated using the diffraction patterns of silver behenate. The 
experimental data were normalized to the transmitted beam intensity, corrected for a non-
homogeneous detector response, and the background scattering of the aqueous buffer was 
subtracted. An automatic sample changer for a sample volume of 15 μL was used. The 
experimental time including sample loading, exposure, cleaning and drying was about 1 min per 
sample. The solvent scattering was measured before and after the sample scattering in order to 
control the eventual sample holder contamination. Four consecutive frames comprising the 
measurements for the solvent, the sample, and the solvent were taken. No measurable radiation 
damage was detected by comparing four successive time frames with 5 s exposures. The final 
scattering curve was obtained using the automated acquisition and analysis by averaging the 
scattering data collected from different frames [17]. 
SANS measurements were carried out at the small-angle diffractometers SANS-II at the 
SINQ spallation neutron source (PSI, Villigen, Switzerland) [18], operating in continuous 
regime, and YuMO at the IBR-2 pulsed reactor (JINR, Dubna, Russia), in time-of-flight regime. 
On SANS-II the scattering data were recorded at sample-detector distances of 1.3 and 4 m, with 
a neutron wavelength of 0.53 nm and wavelength spread of about 10%. The raw data were 
corrected for background, transmission and detector efficiency, and put on the absolute scale 
using the scattering from a 1-mm thick H2O sample, pre-calibrated by scattering from a dilute 
solution of polystyrene. The data were reduced by the BerSANS software package [19]. On the 
YuMO small-angle spectrometer a two-detector set-up with ring wire detectors were used [20]. 
The neutron wavelength range was 0.05-0.8 nm
-1
. The measured scattering curves were corrected 
for background scattering from buffer solutions. For absolute calibration of the scattered 
intensity during the measurements a vanadium standard was used. The raw data treatment was 
performed by the SAS program with a smoothing mode [21]. For the measurements on both 
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instruments the solutions were put in 1 mm thick quartz plain cells (Helma) and kept at room 
temperature. 
 
3. RESULTS AND DISCUSSIONS 
3.1. SAXS and SANS data analysis at full contrast 
As the first step, the SAXS scattering curves for apoferritin and magnetoferritin with the 
minimal LF of 160 are compared in Fig. 1. The scattering curve of apoferritin (LF = 0) is well 
described by the form-factor of a monodisperse spherical shell [22, 23]: 
P(q) = (1/V)
2
 [V1(qR1) – V2(qR2)]
2
, (1) 
where (x) = 3(sin(x) – x cos(x)) / x3; Vi = (4/3)Ri
3
 is the volume of a sphere with radius Ri; R1 
= 6.32 (1) nm and R2 = 3.53 (1) nm are the outer and inner radii of the shell, respectively, and V 
= V1 – V2 is the volume of the shell. The logical extension of this model for the case of 
magnetoferritin is the representation of the macromolecule as a spherical particle with a 
homogeneous, iron oxide containing core and the protein shell. However, this approach cannot 
describe the experimental data obtained, most likely because of modification of the 
magnetoferritin structure under iron oxide loading, which breaks the spherical symmetry. 
Therefore, the data treatment is mainly reduced to the comparative analysis of specific 
characteristics of the curves including the scattering invariants. Thus, in small-angle scattering at 
sufficiently small q-values one can use the Guinier approximation: 
2 2( ) (0)exp( /3)gI q = I R q  (2) 
where the forward scattered intensity 2 2(0) (Δ )I = nV ρ  is determined by the particle number 
density, n, particle volume, V, and the contrast, Δ sρ= ρ ρ  which is the difference between the 
mean scattering length densities (SLDs) of the particle, ρ , and solvent, sρ ; and gR  is the radius 
of gyration, the average of square distances from the center-of-mass of the macromolecule 
weighted by the SLD distribution. Since apoferritin, like most of proteins, is a homogeneous 
object in terms of the inner SLD fluctuations, its radius of gyration is strictly determined by the  
inner and outer radii of the protein shell, 
2 5 5 3 3
1 2 1 2(3/5)( ) /( )gR R R R R   , which gives Rg = 
5.25 nm well testified by the direct approximation of Eq.2 to the experimental curve in the 
Gunier region (q < 0.3 nm
-1
). 
The scattering curve of magnetoferritin solution retains its character typical for a spherical 
shell, but an appreciable smearing of the peaks and a shift of the minima (indicated by arrows in 
Fig. 1) towards larger q-values are observed. The radius of gyration of magnetoferritin found 
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from the Guinier approximation to the experimental curve, 4.99 nm, is slightly smaller than that 
of apoferritin. Also, the total intensity is larger than that for apoferritin with the same 
concentration of protein moiety in the solution; in particular, the forward scattered intensity of 
magnetoferritin exceeds that of apoferritin by 1.7 times. The observed differences cannot be 
attributed to a simple transformation of the hollow apoferritin shell into a core-shell structure 
after the cage is filled with iron oxide. First, the scattering curve of magnetoferritin cannot be 
properly described in terms of a simple model of monodisperse core-shell spheres as such model 
cannot principally explain the observed smearing. Second, the measured increase in the forward 
scattered intensity of magnetoferritin is too high; the volume fraction of magnetic material in the 
system at LF=160 is at the level of 0.005, which should give maximum a 10 % increase in the 
squared contrast relative to apoferritin, which is much below the observation. Since the protein 
shell is monodisperse, the discussed increase in the intensity suggests that the magnetic material 
has a non-uniform distribution over the protein shells. It was reported previously [7,8] that the 
loading of magnetoferritin similar to native ferritin [24,25] is characterized by some distribution 
of the iron content over the cages. From the viewpoint of the scattering theory one deals in this 
case with a distribution of ρ  with the mean value, eρ  (effective mean SLD), and width, p, 
which determines the so-called structural polydispersity [25-27] and gives an additional 
contribution to the scattering. In particular, for the forward scattered intensity one can write: 
2 2 2 2(0) pI = nΔρ V +nσ V , (3) 
where the modified (for polydisperse systems) contrast is determined as se ρρ=ρΔ 
~ . Using the 
experimentally found ratio between the forward scattered intensities for apoferritin and 
magnetoferritin at LF=160 one obtains p = 0.07 e∙Å
-3
 (here for SLD in SAXS we use 
traditionally the units of number of electrons per volume). This is more than ten times larger than 
the difference in the mean SLD of magnetoferritin with LF=160 ( ρ  = 0.425 e∙Å-3) and 
apoferritin ( ρ  = 0.42 e∙Å-3). Thus, the volume fraction of the magnetic material in the cage 
varies in a much wider interval than what can be achieved for magnetoferritin regarded as a 
monodisperse protein cavity with just varying amount of iron oxide. This contradiction suggests 
that the protein shell is partly disassembled. The shell in this case is no longer a monodisperse 
object, and now, in addition to the structural polydispersity, the size polydispersity contributes to 
the scattering as well. The partial disassembling of the shell is indirectly confirmed by modelling 
the scattering curves by indirect Fourier transform (IFT) [28], using the GNOM program [29], 
which represents the scattering data in terms of the pair distance distribution function (PDD) (see 
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inset to Fig. 1). The PDD function for magnetoferritin differs significantly from that of 
apoferritin, which is strongly skewed towards large distances owing to the protein shell around 
the empty cavity. Still, the maximal sizes are close for the two macromolecules. From the 
comparison of the PDD functions of magnetoferritin and a filled sphere with the diameter of 
apoferritin (calculated and plotted additionally in inset to Fig. 1) one can conclude that the 
scattering object in our case has an intermediate shape between spherical shell and sphere. This 
conclusion is also supported by the ab-initio analysis of the scattering data using the DAMMIF 
program [30], which models the shape of the scattering object in the homogeneous 
approximation by representing it with a set of sufficiently small uniform beads (Fig. 2). As 
compared to the scattering from apofferitin, for which DAMMIF, as expected, gives a shape very 
close to a hollow sphere (Fig. 2a), the DAMMIF treatment of the scattering from magnetoferritin 
results in a structure, which deviates strongly from a complete shell (Fig. 2b). It must be noted 
that this structure is some kind of an average shape, which does not exclude the existence of 
complete shells in the solution. The given treatment fully neglects the scattering contribution 
from magnetite. Still, it demonstrates clearly that the explanation of the observed shifts in the 
scattering minima and smearing of the curves requires quite significant deviations from a hollow 
sphere. 
The increase in LF is accompanied by further smearing of the SAXS curves, as one can 
see in Fig. 3a which covers intermediate loading factors up to LF = 430. This is reflected in the 
PDD functions obtained by the IFT procedure (Fig. 3b) as a shift of the particle peak to smaller 
distances, which corresponds to a spherical symmetry violation and a transition to a more 
compact object. Along with it, the character of the curves changes as well, showing some 
specific increase in the forward scattered intensity and the radius of gyration both obtained as a 
result of the IFT procedure (Fig. 4). The latter is an indication of the formation of aggregates of 
magnetoferritin in the solutions with the LF growth. This is reflected in the corresponding PDD 
functions (Fig. 3b) as the appearance of a wide band above r = 12 nm (the expected diameter of 
the complete protein shell) starting from LF = 260. The ratios between the calculated and 
measured values of I(0) and Rg correspond to rather small (< 10) aggregation numbers. Such 
aggregation alone cannot explain the observed smearing of the curves, hence, it points to the 
increasing polydispersity with increasing amount of magnetic material in magnetoferritin. The 
size and structure polydispersity together with the absence of strictly defined scattering form-
factor of the macromolecules prevent the easy determination and separation of the structure-
factor which would correspond to the average effective interactions of the basic structural units 
(here, magnetoferritin macromolecules) in the solutions like in the case of homogeneous or 
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multilayered structures [31, 32]. Instead, the structures formed resemble more the partly 
aggregated particles in aqueous dispersions of magnetite nanoparticles coated with surfactant 
shells [33]. 
The SANS curves (Fig. 5a) and the corresponding PDD functions (Fig. 5b) for another 
series of magnetoferritin solutions cover a more extended interval over LFs, up to LF = 800. For 
the intermediate LFs (LF < 600) the similar treatment generally repeats the previous conclusions 
of the SAXS analysis; yet, the aggregate effect starts to be visible at higher LF and is 
characterized by smaller aggregate size for the second series. At the same time, starting from LF 
= 600 a tendency towards a sharp increase in the aggregation is seen, which is well distinguished 
as a drastic widening of the corresponding PDD functions (Fig. 5b). A further increase in LF 
would make it impossible to treat the curves in the same way at the given instrumental 
resolution, which is determined by the minimal q-value corresponding to the detectable maximal 
size of the scattering objects. The formation of stable aggregates in magnetoferritin solutions 
with the LF growth is confirmed by the DLS measurements from diluted solutions. In Fig. 6 the 
LF-dependences of the mean hydrodynamic radius, <Rhydr>, and of radius of gyration obtained 
by SAXS and SANS are compared. For apoferritin the <Rhydr>-value is fully consistent with the 
small-angle scattering data if one takes into account that in this case, the radius of gyration 
corresponds to the radius of the hollow protein shell of about 6 nm, and the hydrodynamic radius 
naturally exceeds this value by about 10%. A non-monotonic size growth is revealed in the three 
kinds of experiments, as shown in Fig. 6 from which one can reliably conclude that a tendency to 
a slight aggregation of magnetoferritin is seen at LF over the interval of 160 – 510, and the 
aggregation becomes more intensive at LF above 600. The discussed LF-dependences do not 
fully repeat themselves most probably because of a strong sensitivity to stochastic factors during 
the sample preparation (e.g. intensity and time of solution deaeration and stirring), which is 
typical for liquid dispersions of nanoparticles. 
It is interesting to compare the size characteristics of magnetoferritin with those of ferritin 
(Figs. 3, 5, 6) in solutions under the same conditions. The natural LF-values of ferritin (the core 
has a ferrihydrite-like structure) are close to LF = 2000. One can see that despite the large iron 
content the scattering curves from ferritin show more pronounced oscillating behaviour, thus 
reflecting rather high monodispersity and structural stability of this macromolecule. At the same 
time, the corresponding PDD functions (Figs. 3 b, 5 b) indicate that the ferritin solutions are not 
free of some small aggregates; still, their mean size is significantly lower as compared to the 
solutions of magnetoferritin. 
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The disassembling of the protein shell in apoferritin can take place under some 
conditions, in particular in strongly acidic solutions [34]. Thus, it was shown that the complete 
disappearance of the characteristic peaks in SAXS curves from disassembled apoferritin strictly 
takes place when 12 out of the 24 structural units are removed from the shell. In our experiments 
pH was kept constant at 8.6, which is optimal for the stability of apoferritin structure, but the 
character of the observed smearing of the scattering curves was the same, thus indicating that in 
average about half of the apoferritin shell in magnetoferritin is destroyed when LF approaches 
1000. 
 
3.2. SANS contrast variation 
The contrast variation technique in SANS experiments on moderately polydisperse 
objects makes it possible to conclude about the polydispersity degree in terms of the weighted 
averaged scattering length density distribution over the studied particles [26]. For this purpose 
the scattering from the system under study is analysed, varying the content of a deuterated 
component of the solvent. Here, the SANS contrast variation data based on substitution of light 
(H2O) for heavy (D2O) water is used to conclude about the change in the polydispersity with 
rising LF. The samples with low (LF = 160) and relatively high (LF = 510) loading factors were 
investigated. The upper LF-value was chosen to avoid the large aggregation which starts, as 
shown above, at LF of about 600. The Guinier region for the different contrasts (Fig. 7) was used 
to determine the I(0) parameter according to Eq. 1. I(0) as a function of the volume fraction of 
D2O is shown in Fig. 8; its minimum for the case of polydisperse particles corresponds to the 
effective match point [26]. At the considered LF-values the additional magnetic neutron 
scattering contribution can be neglected. The upper estimates give for LF=510 that its 
contribution to the forward scattered intensity is less than 2%. Already in the monodisperse 
approximation, under the assumption that the magnetic core in magnetoferritin consists of 
magnetite (Fe3O4, SLD = 6.9∙10
10
 cm
-2
), the shifts of the effective match points (the 
corresponding SLDs are 2.46∙1010 cm-2 and 2.79∙1010 cm-2 for LF=160 and LF=510, 
respectively) as compared to the protein moiety of apoferritin (SLD 2.34∙1010 cm-2) give 0.026 
and 0.099, respectively, for the volume fractions of magnetic material in the protein cage. These 
values are much larger than the amount of iron loaded during the synthesis (0.005 and 0.017 for 
LF=160 and LF=510, respectively). Assuming maghemite (Fe2O3, SLD = 6.7∙10
10
 cm
-2
) in the 
magnetic core, the result would differ by less than 5%. 
The obtained match points are significantly higher than those expected for a core filled 
with iron oxides. Therefore, the SANS contrast variation strongly points to an abnormally high 
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average ratio between the content of the magnetic material and protein, which can be explained 
by the partial disassembling of the shell, leading to an effective growth of the relative content of 
the magnetic component in the structure of magnetoferritin. The residual scattering in the 
effective match points, which is an indicator of polydispersity, increases, thus explaining the 
broadening of the polydispersity for larger LFs. This is consistent with the smearing of the 
scattering curves with the LF growth in Figs. 3a, 5a. 
It should be noted that despite the concluded disassembling of the protein shell the 
magnetoferritins remain soluble as a whole. Also, the solutions themselves are stable for at least 
three months, without signs of precipitates. The mechanism of the effect of magnetic loading on 
the protein structure is unclear. As mentioned previously, apoferritin disassembly was observed 
at pH below 3.4 [34], which, however, is not our case, since magnetoferritin was prepared in 
alkaline pH 8.6 and anaerobic conditions. While it is not possible to control pH directly during 
the synthesis process, after the synthesis the pH value was checked and only slight decrease for 
higher LFs was detected, remaining above pH 7 for all LFs. 
One can relate the observed structural change of the protein with a specific effect of 
magnetic nanoparticles placed in the cavity on the protein shell. So far there is no general 
understanding of interactions between nanoparticles and proteins despite of the extensive studies 
of this problem in recent years. In particular, the interaction of various nanoparticles with 
specific protein aggregates (amyloids) can be mentioned. Among different types of probed 
materials [35] magnetic nanoparticles of iron oxides show inhibiting and even disaggregating 
effect on amyloidal aggregation [36-40]. 
 
CONCLUSIONS 
In summary, the combined SAXS/SANS analysis complemented by DLS measurements 
of magnetoferritin aqueous solutions at loading factors in the interval of 160 – 800 reveals two 
competitive effects when increasing the LF. First, a partial disassembling of apoferritin shell in 
magnetoferritin, starting from the smallest of the applied LFs is observed. The effect increases 
with the LF growth and, in addition to the structure polydispersity (distribution of loading over 
the proteins), results in a moderate size polydispersity of magnetoferritin. Second, at LFs above 
160 a tendency towards slight aggregation (aggregation number below 10) of magnetoferritin is 
observed; it takes place in a wide protein concentration interval of 0.2 – 20 mg ml-1 but is rather 
sensitive to the preparation procedure. The aggregation becomes more intensive at LFs above 
600.  
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Fig. 1. Experimental SAXS curves for apoferritin and magnetoferritin with low LF. Smearing 
and shift of minima are indicated by arrows against the first minimum. Solid lines correspond to 
the model curves obtained by DAMMIF (see text). Relative experimental errors at q < 1.8 nm
-1
 
do not exceed 1%. Inset shows PDD functions of apoferritin and magnetoferritin (results of the 
IFT treatment of the experimental curves) and a sphere with radius of 6 nm (model calculations). 
 
      
 
Fig. 2. Bead models of apoferritin (a) and magnetoferritin with LF=160 (b) obtained by the 
DAMMIF procedure on the data shown in Fig. 1. 
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Fig. 3. SAXS data for magnetoferritin with different LF (intermediate values are covered) and 
comparison with apoferritin (LF = 0) and ferritin (LF = 1990): experimental scattering curves (a) 
and PDD functions as a result of IFT treatment (b). The relative experimental errors in the 
scattering data points at q < 1.8 nm
-1
 do not exceed 1%. The concentrations of proteins are 2.35 
mg∙mL
-1
 for apoferritin, 44 mg∙mL
-1
 for ferritin, and 2.81 mg∙mL
-1
 for magnetoferritin LF160, 
7.18 mg∙mL
-1
 LF260, 6.96 mg∙mL
-1
 LF350, 7.95 mg∙mL
-1
 LF410, 8.14 mg∙mL
-1
 LF430. For 
convenient view the curves in (a) are shifted vertically by multiplying by the factor indicated at 
the right. In (a) the solid lines show the IFT fits. 
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Fig. 4. LF-dependences of I(0) and Rg found by the IFT treatment of the SAXS experimental 
curves in Fig. 3a. The lines are plotted to follow the tendencies. Experimental errors do not 
exceed the size of the points. 
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Fig. 5. SANS data for magnetoferritin with different LF (high values are covered) and 
comparison with apoferritin (LF = 0) and ferritin (LF = 1990): experimental scattering curves (a) 
and PDD functions as a result of the IFT treatment (b). In (a) the relative experimental errors do 
not exceed 5 %. The protein concentration in all magnetoferritin solutions based on D2O is 20 
mg∙mL
-1
. The concentrations of proteins are 2.35 mg∙mL
-1
 in apoferritin and 44 mg∙mL
-1
 in 
ferritin solutions. For convenient view data in (a) are shifted vertically by multiplying by the 
indicated factor. In (a) the solid lines show the IFT fits. 
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Fig. 6. LF-dependences of hydrodynamic radius (DLS data) and radius of gyration (SAXS and 
SANS data, IFT treatment) of magnetoferritin for different series of samples and comparison 
with the corresponding values of apoferritin (Apo) and ferritin. For SAXS and SANS data the 
experimental errors do not exceed the size of the points. The lines are plotted to follow the 
tendencies. 
 
 
 
Fig. 7. Guinier plots for SANS contrast variation data for magnetoferritin solutions with LF 160 
(a) and LF 510 (b). 
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Fig. 8. The change in the forward scattered intensity I(0) for two samples of magnetoferritin 
(loading factors LF=160 and LF=510) solutions with varying volume fraction of D2O, , in the 
solvent. The experimental errors do not exceed the size of the points. Effective match points 
corresponding to the intensity minima are indicated by vertical arrows. 
 
 
